Publication:
Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention

dc.contributor.authorParr, C.es
dc.contributor.authorJiang, W.G.es
dc.date.accessioned2011-05-11T10:55:46Z
dc.date.available2011-05-11T10:55:46Z
dc.date.issued2001
dc.description.abstractHepatocyte growth factor (HGF), otherwise known as scatter factor (SF), has been demonstrated over the past decade to elicit a number of functions that may be tumorigenic, and enhance the invasive/metastatic nature of cancer cells. Clinical studies have also demonstrated that HGFJSF, together with its receptor, cMET, is closely related to the disease progression and prognosis of patients with cancer. The past few years have seen the identification of numerous inhibitors and antagonists to the action of HGFISF. These factors have demonstrated a possible role in minimising the action of HGFISF on cancer cells, and may be of therapeutic value in the future. This article overviews the activators, inhibitors, and antagonists to HGFISF and discusses the possible implications in cancer therapy.es
dc.formatapplication/pdfes
dc.format.extent18es
dc.identifier.issn0213-3911es
dc.identifier.urihttp://hdl.handle.net/10201/20651
dc.languageenges
dc.publisherMurcia : F. Hernándezes
dc.relation.ispartofHistology and histopathologyes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectHepatocyte growth factores
dc.subjectcMET protooncogenees
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleHepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer interventiones
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hepatocyte growth factor activators inhibitors and antagonists and their implication in cancer intervention.pdf
Size:
11.44 MB
Format:
Adobe Portable Document Format
Description: